Alternatives to ranitidine
3 same-class SPL records vs ranitidine - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Zantac
How to read a high-report FAERS peer set
ranitidine ranks in the upper FAERS-volume third of the corpus (#28 of 524); 3 same-class peers are listed for field comparison only. Labeled indication field for ranitidine: This medicine treats heartburn caused by acid indigestion and sour stomach.
Top FAERS reaction fields for ranitidine total 139,052 reports across 10 reactions, set beside cimetidine, famotidine, nizatidine. Counts are exposure-weighted submissions, not per-patient risk.
About ranitidine
Ranitidine (Zantac) helps reduce stomach acid. It can relieve heartburn and sour stomach.
Used for: This medicine treats heartburn caused by acid indigestion and sour stomach. You can also take it to prevent heartburn. It can prevent heartburn caused by eating or drinking certain foods and drinks.
3 H2 Receptor Antagonist peers (wide set)
cimetidine
OTCTagamet
Cimetidine treats active duodenal ulcers for short periods. It can also be used long-term at a lower dose to prevent ulcers from returning. This medicine also treats active benign gastric ulcers for a short time. Additionally, it can help with erosive gastroesophageal reflux disease (GERD), which damages the esophagus.
famotidine
OTCPepcid
This medicine treats active duodenal ulcers and active gastric ulcers. It also treats heartburn (nonerosive GERD) and erosive esophagitis (damage to the esophagus from acid reflux). Famotidine can also treat conditions where the stomach makes too much acid, like Zollinger-Ellison syndrome. It can also lower the risk of duodenal ulcers coming back.
nizatidine
OTCAxid
Nizatidine can treat active duodenal ulcers for up to 8 weeks. It can also be used long-term at a lower dose to prevent ulcers from returning. Nizatidine treats esophagitis (damage to the esophagus) and heartburn caused by GERD for up to 12 weeks. It can also treat active benign gastric ulcers for up to 8 weeks.
ranitidine vs cimetidine & famotidine · FAERS reaction fields
FAERS top-reaction field "Breast Cancer" shows the widest count spread between ranitidine and cimetidine, famotidine, nizatidine in this extract (24,853-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | ranitidine | cimetidine | famotidine | nizatidine |
|---|---|---|---|---|
| Breast Cancer | 24,853 | - | - | - |
| Prostate Cancer | 22,252 | - | - | - |
| Colorectal Cancer | 17,674 | - | - | - |
| Bladder Cancer | 16,746 | - | - | - |
| Renal Cancer | 16,278 | - | - | - |
| Oesophageal Carcinoma | 9,648 | - | - | - |
| Incorrect Dose Administered | 9,631 | - | - | - |
| Hepatic Cancer | 7,592 | - | - | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
ranitidine FAERS volume vs class peers
FAERS volume band
ranitidine is FAERS corpus rank #28 of 524 (high volume tercile). Top-reaction field total: 139,052.
Frequently Asked Questions
Where does ranitidine sit in FAERS report volume vs H2 Receptor Antagonist peers? ▼
Registry note: FAERS counts are voluntary reports and do not establish causation or risk rates. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for ranitidine: see also the generic vs brand label guide when reading Zantac SPL strings.
Read our methodology - how this data is sourced, computed, and verified.